Truncated APC regulates alternative splicing by interacting with DDX21 in colorectal cancer.
Year: 2026
Type: article
Abstract: Truncating mutations in the adenomatous polyposis coli (APC) gene-a key driver of colorectal cancer (CRC) initiation-frequently lead to the production of a truncated APC protein (Trunc-APC). However, its post-transcriptional roles and oncogenic potential remain largely unexplored. Here, we demonstrate that Trunc-APC functions as an RNA-binding protein, directly associating with pre-mRNA via its N-terminal 1-169 amino acid region to regulate widespread alternative splicing (AS) in CRC cells. Specifically, Trunc-APC promotes exon inclusion in ARHGEF11, producing an oncogenic isoform that is associated with enhanced Bcl-xL/BAX complex formation and reduced apoptosis. Mechanistically, Trunc-APC interacts with the RNA helicase DDX21 and facilitates SF3B complex recruitment to pre-mRNA, thereby modulating splicing patterns. Notably, treatment with the splicing inhibitor Madrasin significantly reduced tumor burden in ApcMin/+ CRC mice, indicating strong antitumor efficacy. Collectively, these findings establish Trunc-APC as a novel regulator of alternative splicing and a promoter of CRC progression, and highlight the therapeutic potential of targeting the Trunc-APC/DDX21/SF3B axis in CRC.
Source: PubMed
DOI: 10.1093/nar/gkag1153
Institutions: Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, University of Electronic Science and Technology of China, Sichuan Cancer Hospital, State Key Laboratory of Respiratory Disease, Guangzhou Chest Hospital, Guangzhou Medical University, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University
Language: English
Topic: RNA Research and Splicing
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7225813505
